A detailed history of Geode Capital Management, LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,732,270 shares of RLAY stock, worth $12.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,732,270
Previous 2,364,797 15.54%
Holding current value
$12.2 Million
Previous $15.4 Million 25.46%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$6.23 - $9.51 $2.29 Million - $3.49 Million
367,473 Added 15.54%
2,732,270 $19.3 Million
Q2 2024

Aug 09, 2024

BUY
$5.9 - $8.02 $873,223 - $1.19 Million
148,004 Added 6.68%
2,364,797 $15.4 Million
Q1 2024

May 13, 2024

BUY
$7.5 - $12.07 $1.01 Million - $1.63 Million
135,283 Added 6.5%
2,216,793 $18.4 Million
Q4 2023

Feb 13, 2024

BUY
$6.01 - $11.48 $664,237 - $1.27 Million
110,522 Added 5.61%
2,081,510 $22.9 Million
Q3 2023

Nov 13, 2023

BUY
$8.24 - $12.97 $739,358 - $1.16 Million
89,728 Added 4.77%
1,970,988 $16.6 Million
Q2 2023

Aug 11, 2023

BUY
$9.99 - $18.27 $1.27 Million - $2.32 Million
126,730 Added 7.22%
1,881,260 $23.6 Million
Q1 2023

May 15, 2023

BUY
$15.0 - $22.76 $906,135 - $1.37 Million
60,409 Added 3.57%
1,754,530 $28.9 Million
Q4 2022

Feb 13, 2023

BUY
$14.16 - $24.02 $2.03 Million - $3.44 Million
143,146 Added 9.23%
1,694,121 $25.3 Million
Q3 2022

Nov 14, 2022

BUY
$18.07 - $31.37 $2.25 Million - $3.9 Million
124,251 Added 8.71%
1,550,975 $34.7 Million
Q2 2022

Aug 12, 2022

BUY
$13.31 - $34.88 $988,227 - $2.59 Million
74,247 Added 5.49%
1,426,724 $23.9 Million
Q1 2022

May 13, 2022

BUY
$20.26 - $32.36 $961,559 - $1.54 Million
47,461 Added 3.64%
1,352,477 $40.5 Million
Q4 2021

Feb 11, 2022

BUY
$26.0 - $37.03 $6.23 Million - $8.88 Million
239,756 Added 22.51%
1,305,016 $40.1 Million
Q3 2021

Nov 12, 2021

BUY
$29.75 - $37.99 $10.6 Million - $13.6 Million
357,365 Added 50.48%
1,065,260 $33.6 Million
Q2 2021

Aug 13, 2021

BUY
$27.5 - $38.19 $2.86 Million - $3.97 Million
103,962 Added 17.21%
707,895 $25.9 Million
Q1 2021

May 12, 2021

BUY
$32.52 - $61.53 $5.14 Million - $9.72 Million
157,909 Added 35.4%
603,933 $20.9 Million
Q4 2020

Feb 12, 2021

BUY
$35.51 - $54.03 $321,081 - $488,539
9,042 Added 2.07%
446,024 $18.5 Million
Q3 2020

Nov 13, 2020

BUY
$32.81 - $45.1 $14.3 Million - $19.7 Million
436,982 New
436,982 $18.6 Million

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $537M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.